1. Home
  2. HURC vs MNOV Comparison

HURC vs MNOV Comparison

Compare HURC & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hurco Companies Inc.

HURC

Hurco Companies Inc.

N/A

Current Price

$21.60

Market Cap

136.8M

Sector

Industrials

ML Signal

N/A

Logo Medicinova Inc

MNOV

Medicinova Inc

SELL

Current Price

$1.48

Market Cap

137.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HURC
MNOV
Founded
1968
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.8M
137.8M
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
HURC
MNOV
Price
$21.60
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $8.25
AVG Volume (30 Days)
15.9K
★ 101.6K
Earning Date
09-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.59
N/A
EPS
N/A
★ N/A
Revenue
★ $178,554,000.00
$2,360,807.00
Revenue This Year
N/A
$78.20
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 194.15
52 Week Low
$14.50
$1.20
52 Week High
$24.49
$3.90

Technical Indicators

Market Signals
Indicator
HURC
MNOV
Relative Strength Index (RSI) 55.59 41.19
Support Level $20.59 $1.28
Resistance Level $23.00 $1.54
Average True Range (ATR) 0.70 0.06
MACD 0.11 0.01
Stochastic Oscillator 78.06 47.00

Price Performance

Historical Comparison
HURC
MNOV

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: